Saturn V Capital Management »

Abivax SA F shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.9M 623k 14.30

More positions owned by Saturn V Capital Management

Crinetics Pharmaceuticals In (CRNX)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Kalvista Pharmaceuticals (KALV)
Merus N V (MRUS)
Disc Medicine (IRON)
Ascendis Pharma A/s Sponsored Adr (ASND)
Anaptysbio Inc Common (ANAB)
Vaxcyte (PCVX)
Cogent Biosciences (COGT)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Syndax Pharmaceuticals (SNDX)
Abivax Sa Sponsored Ads (ABVX)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Saturn V Capital Management

Top funds holding Abivax SA F

Dr. Jeffrey R. Jay, M.D.
Cormorant Asset Management
Blackstone Group
Commodore Capital
Franklin Resources
VR Adviser
Nantahala Capital Management
Henderson Group
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Citadel Advisors
Adage Capital Partners GP
Point72 Asset Management
Rosalind Advisors

View all funds holding Abivax SA F